论文部分内容阅读
沈阳三生制药股份有限公司,成立于1993年,是国家卫生部批准的基因工程制品定点生产单位。 三生公司投资8000万元兴建的现代化生物技术厂房,座落于国家级沈阳经济技术开发区。厂区占地约30000平方米,建筑面积10000多平方米,严格按照GMP管理要求设计和施工。设计年产基因工程干扰素α—2a(商品名:因特芬)、白细胞介素-2(商品名:英路因)和红细胞生成素等基因工程制剂50C万支。这是国内规模最大的、具有国际水平的基因工程制药基
Shenyang Sansheng Pharmaceutical Co., Ltd., founded in 1993, is a designated producer of genetically engineered products approved by the Ministry of Health. Sansheng invested 80 million yuan to build a modern biotechnology plant, located in the state-level Shenyang Economic and Technological Development Zone. Plant covers an area of about 30,000 square meters, construction area of over 10,000 square meters, in strict accordance with the GMP management requirements of the design and construction. Designed to produce genetic engineering interferon α-2a (product name: Interferon), interleukin-2 (product name: British factor) and erythropoietin gene engineering preparations such as 50 million. This is the largest and world-class genetic engineering pharmaceutical base